Index Keywords

↶ Return
New
Edit
History
Source

Mitochondria and Skin Aging

Mitochondria and Skin Aging describes how mitochondrial dysfunction links intrinsic aging and photoaging to collagen loss, pigmentary imbalance, barrier dysfunction, and delayed tissue repair.[1]

Overview

  • Mitochondria supply ATP and coordinate redox signaling, mitophagy, and cell-fate control that support fibroblast collagen synthesis, keratinocyte proliferation, melanocyte homeostasis, and efficient wound repair in skin.[1:1]
  • The review frames mitochondria as a central, modifiable hub in cutaneous aging rather than a secondary bystander of skin damage.[1:2]

Core Drivers

  • Aging and cumulative ultraviolet exposure promote mtDNA mutations and deletions, impaired oxidative phosphorylation, excess mitochondrial ROS, reduced mitophagy and biogenesis, disrupted fission-fusion dynamics, NAD+ decline, and sirtuin dysregulation.[1:3]
  • Photoexposed skin carries higher mtDNA deletion burdens and lower mtDNA copy numbers than protected skin, and blue light can also induce mtDNA strand breaks and ROS accumulation in dermal fibroblasts.[1:4]
  • Mitochondrial metabolite decline perturbs chromatin-modifying enzymes and retrograde signaling, contributing to fibroblast senescence and reduced expression of extracellular-matrix genes such as COL1A1, COL3A1, and ELN.[1:5]
  • Damaged mitochondria release mtDAMPs such as oxidized mtDNA, cardiolipin, and N-formyl peptides that activate TLR9, cGAS-STING, and NLRP3, reinforcing chronic inflammaging in aging skin.[1:6]
  • Reduced TFAM and PGC-1alpha expression, along with impaired PINK1/Parkin or BNIP3/NIX quality-control pathways, allow depolarized mitochondria to accumulate and impair wound repair.[1:7]
  • Excess DRP1-mediated fission, loss of MFN1, MFN2, and OPA1 function, and cristae disruption lower membrane potential, reduce ATP production, and weaken extracellular-matrix output.[1:8]
  • Age-related NAD+ loss from lower synthesis and higher PARP1/2 and CD38 consumption weakens SIRT1 and SIRT3 programs that normally support mitochondrial biogenesis, detoxification, and redox balance.[1:9]
  • Mitochondrial dysfunction also undermines epithelial stem-cell flexibility, epidermal lipid synthesis, barrier integrity, and regenerative capacity.[1:10]
  • Environmental stressors including UV radiation, ozone, fine particulates, blue light, and IR-A amplify mtROS, mtDNA damage, barrier dysfunction, and extrinsic skin aging.[1:11]

Skin-Level Consequences

  • The downstream phenotype includes fibroblast senescence, collagen and elastin loss, dermal thinning, visible wrinkling, pigmentary imbalance, impaired barrier repair, delayed re-epithelialization, and slower wound closure.[1:12]
  • The review argues that these structural and functional changes emerge from the convergence of bioenergetic failure, redox imbalance, disrupted mitochondrial turnover, and chronic inflammatory signaling.[1:13]

Therapeutic Directions

  • The review highlights NAD+ boosters and sirtuin activators, mitochondria-directed antioxidants such as melatonin and CoQ10, NRF2-directed redox modulators, red and near-infrared photobiomodulation, extracellular-vesicle delivery systems, hormonal and circadian alignment, and experimental mitochondrial transplantation as major intervention classes.[1:14]
  • NR and NMN are described as restoring NAD+ pools, re-engaging SIRT1 -> PGC-1alpha -> NRF1/2 -> TFAM signaling, improving collagen synthesis, and accelerating wound closure in preclinical models.[1:15]
  • Melatonin is presented as a mitochondria-concentrating antioxidant that preserves membrane potential and ATP, boosts antioxidant enzymes, promotes PINK1/Parkin-dependent mitophagy, lowers UVB-induced apoptosis, and improves collagen organization in aged skin samples.[1:16]
  • CoQ10 is summarized as reducing lipid peroxidation, dampening MAPK -> AP-1 and MMP-1 induction, and improving wrinkles and elasticity in clinical and ex vivo human studies.[1:17]
  • NRF2-activating compounds are described as preserving mitochondrial membrane potential and ATP, lowering MMP-1, suppressing MAPK/NF-kappaB signaling, and improving dermal architecture in photoaging models.[1:18]
  • Red and near-infrared photobiomodulation is described as stimulating cytochrome c oxidase, increasing ATP and procollagen, reducing UV-induced ROS and DNA damage, and improving barrier-gene expression when properly dosed, while excessive blue light is counterproductive.[1:19]
  • Engineered extracellular vesicles loaded with NMN, metformin, GSTM2 mRNA, or antioxidant cargo are described as restoring mitophagy, oxidative phosphorylation, dermal thickness, and wound repair in aged models.[1:20]
  • The review argues that biomarker-guided, multimodal, and circadian-aware combinations are likely to outperform single-mechanism interventions because they address mitochondrial biogenesis, mitophagy, redox balance, and collagen anabolism at the same time.[1:21]

Translation Notes

  • The paper emphasizes that most human clinical evidence remains early, with small cohorts, short treatment windows, and limited randomized data, so larger trials with standardized dermatologic endpoints are still needed.[1:22]
  • The review also notes that mitochondria-targeted therapies should complement established skin-protection measures such as UV protection rather than replace them.[1:23]

Footnotes

  1. Study Type: Review
    Title: The Mitochondrial Blueprint of Skin Aging: From Damage Signals to Dermatologic Interventions
    Author(s): Sarah M. Antonevich, Kate M. Miller, Shasa Hu, Monica Rodriguez-Silva, Carlos T. Moraes, and Ivan Jozic
    Institution(s): Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA; Department of Neurology, University of Miami Miller School of Medicine, Miami, Florida, USA
    Publication: Aging and Disease
    Date: March 4, 2026
    Link: Source ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎